PDCD1 and Hodgkins lymphoma: When dealing with haematologic malignancies, first reports of anti-PD1-therapy in Hodgkin lymphoma (HL) were published already in 2014 [47], where a combination of CT and PET/CT imaging was used in order to assess response to immunotherapy.